arginine has been researched along with chalcone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T; Konturek, SJ; Majka, J; Pytko-Polonczyk, J; Szlachcic, A | 1 |
| Akhtar, MN; Akira, A; Israf, DA; Kamaldin, MN; Lajis, N; Ming-Tatt, L; Mohamad, AS; Perimal, EK; Sulaiman, MR | 1 |
| Kong, C; Liu, S; Liu, X; Liu, Z; Piao, C; Yin, L; Zhang, Z | 1 |
3 other study(ies) available for arginine and chalcone
| Article | Year |
|---|---|
Implications of nitric oxide in the action of cytoprotective drugs on gastric mucosa.
Topics: Aluminum Hydroxide; Animals; Anti-Ulcer Agents; Arginine; Chalcone; Chalcones; Dose-Response Relationship, Drug; Drug Combinations; Ethanol; Gastric Mucosa; Magnesium Hydroxide; Male; Nitric Oxide; Nitroarginine; Organometallic Compounds; Prostaglandins F, Synthetic; Rats; Rats, Wistar; Regional Blood Flow; Sucralfate; Vasodilator Agents | 1993 |
Peripheral antinociception of a chalcone, flavokawin B and possible involvement of the nitric oxide/cyclic guanosine monophosphate/potassium channels pathway.
Topics: Analgesics; Animals; Arginine; Carrageenan; Chalcone; Cyclic GMP; Disease Models, Animal; Flavonoids; Hyperalgesia; Male; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Rats; Signal Transduction | 2013 |
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
Topics: Arginine; Biological Products; Chalcone; Enzyme Inhibitors; Histones; Humans; Molecular Docking Simulation; Protein-Arginine N-Methyltransferases; Urinary Bladder Neoplasms | 2022 |